[논문]Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

Van Hoogstraten, H.J.F.; Wolfhagen, F.H.J.; van de Meeberg, P.C.; Kuiper, H.; Nix, G.A.J.J.; Becx, M.C.J.M.; Hoek, A.C.; van Houte, D.P.F.; Rijk, M.C.M.; Salemans, J.M.J.I.; Scherpenisse, J.; Schrijver, M.; Smit, A.M.; Spoelstra, P.; Stadhouders, P.H.G.M.; Tan, T.G.; Hop, W.C.J.; ten Kate, F.J.W.; vanBerge-Henegouwen, G.P.; Schalm, S.W.; van Buuren, H.R.

doi:10.1016/S0168-8278(98)80059-7

[해외논문] Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

Journal of hepatology : the journal of the European Association for the Study of the Liver, v.29 no.3, 1998년, pp.417 - 423

Van Hoogstraten, H.J.F. , Wolfhagen, F.H.J. , van de Meeberg, P.C. , Kuiper, H. , Nix, G.A.J.J. , Becx, M.C.J.M. , Hoek, A.C. , van Houte, D.P.F. , Rijk, M.C.M. , Salemans, J.M.J.I. , Scherpenisse, J. , Schrijver, M. , Smit, A.M. , Spoelstra, P. , Stadhouders, P.H.G.M. , Tan, T.G. , Hop, W.C.J. , ten Kate, F.J.W. , vanBerge-Henegouwen, G.P. , Schalm, S.W. , van Buuren, H.R.

Abstract ▼ AI-Helper

Background/Aims: Ursodeoxycholic acid has been reported to be of potential benefit for primary sclerosing cholangitis but little is known about the long-term biochemical, histological and radiological efficacy or the optimum frequency of ursodeoxycholic acid administration.Methods: A 2-year multicentre randomised controlled trial was initiated to assess the effects of ursodeoxycholic acid (10 mg . kg-1 . d-), given in either single or multiple daily doses, on symptoms, serum liver tests, cholangiographic and histological findings and the occurrence of treatment failure. Liver biopsies were taken and endoscopic retrograde cholangiography was performed at entry and after 2 years; follow-up examinations were at 3-month intervals. Treatment failure was defined as death, liver transplantation, 4-fold increase in serum bilirubin, variceal bleeding, de novo ascites or cholangitis. Actuarial survival was compared with predicted survival using the revised Mayo natural history model for primary sclerosing cholangitis.Results: Forty-eight patients were enrolled. In one case, ursodeoxycholic acid had to be discontinued because of gastro-intestinal complaints. No other side-effects were observed. Afte 2 years of follow-up, treatment was not associated with a beneficial effect on either symptoms or liver histology. Serum liver tests (alkaline phosphate, γ-glutamyl transferase, aspartate aminotransferase) improved significantly in both groups, while serum bilirubin (which was near normal at entry) and IgG remained stable. No major changes in radiographic bile duct appearance seemed to be present. After 2 years, actuarial survival was 91% (95 CI 83%-99%), which is comparable to the predicted 97% survival rate. Treatment failure occurred in 15% of cases. No significant differences in any of the study endpoints (symptoms, serum liver tests, cholangiographic findings, histology, disease progression) were found between the two groups.Conclusions: Ursodeoxycholic acid is well obtained in primary sclerosing cholangitis. Significant effects on biochemical parameters were found and symptoms, bilirubin and histology did not deteriorate. No advantage of a multiple daily dose over a single dose was observed.

주제어

참고문헌 (27)

N Engl J Med Lee 332 924 1995 10.1056/NEJM199504063321406 Primary sclerosing cholangitis

상세보기
J Hepatol Broome 20 654 1994 10.1016/S0168-8278(05)80356-3 Assessment for liver transplantation in patients with primary sclerosing cholangitis

상세보기
Gastroenterology LaRusso 95 1036 1988 10.1016/0016-5085(88)90180-1 Prospective trial of penicillamine in primary sclerosing cholangitis

상세보기
Gastroenterology Knox 106 494 1994 10.1016/0016-5085(94)90610-6 A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

상세보기
Gastroenterology Olsson 108 1199 1995 10.1016/0016-5085(95)90220-1 Colchicine treatment of primary slerosing cholangitis

상세보기
Gastroenterology Leuschner 97 1268 1989 10.1016/0016-5085(89)91698-3 Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

상세보기
N Engl J Med Poupon 324 1548 1991 10.1056/NEJM199105303242204 A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis

상세보기
Hepatology O'Brien 14 838 1991 10.1002/hep.1840140516 Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study

상세보기
J Hepatol Chazouilleres 11 120 1990 10.1016/0168-8278(90)90281-U Ursodeoxycholic acid for primary sclerosing cholangitis

상세보기
Hepatology Beuers 16 707 1992 10.1002/hep.1840160315 Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

상세보기
J Hepatol Stiehl 20 57 1994 10.1016/S0168-8278(05)80467-2 Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

상세보기
Gastroenterology Mitchell 112 1335 1997 High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): results after two years of a randomised double-blind, placebo-controlled trial [abstract]
N Engl J Med Lindor 336 691 1997 10.1056/NEJM199703063361003 Ursodiol for primary sclerosing cholangitis

상세보기
J Hepatol van de Meeberg 25 887 1996 10.1016/S0168-8278(96)80293-5 Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response

상세보기
Hepatology Lacerda 104 933 1993 Ursodiol in primary biliary cirrhosis (PBC): enrichment correlates with biochemical improvement [abstract]
Gut Jorgensen 36 935 1995 10.1136/gut.36.6.935 Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

상세보기
Hepatitis Colombo 16 924 1992 Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study
Gastroenterology Walker 102 810 1992 10.1016/0016-5085(92)90162-R Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage

상세보기
Br Med J Truelove 2 1041 1955 10.1136/bmj.2.4947.1041 Cortisone in ulcerative colitis
Aliment Pharmacol Ther Hodgson 5 555 1991 10.1111/j.1365-2036.1991.tb00525.x Review article: assessment of drug therapy in inflammatory bowel disease

상세보기
Hepatology Ludwig 1 632 1991 10.1002/hep.1840010612 Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

상세보기
Liver Van Eyken 13 113 1993 10.1111/j.1600-0676.1993.tb00617.x Cytokeratins and the liver

상세보기
Hepatology Kim 26 362 1997 A revised natural history model for primary sclerosing cholangitis obviates the need for liver histology [abstract]
Gastrointest Radiol Chen 9 39 1984 10.1007/BF01887799 Sclerosing cholangitis: broad spectrum of radiographic features

상세보기
Am J Roentgenol Majoie 157 495 1991 10.2214/ajr.157.3.1651643 Primary sclerosing cholangitis: a modified classification of cholangiographic findings

상세보기
Am J Roentgenol Craig 157 959 1991 10.2214/ajr.157.5.1927817 Primary sclerosing cholangitis: value of cholangiography in determining the prognosis

상세보기
Dig Dis Sci Podda 34 59 1989 10.1007/BF01536665 Effect of different doses of ursodeoxycholic acid in chronic liver disease

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

[해외논문] Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

Abstract ▼ AI-Helper

주제어

참고문헌 (27)

이 논문을 인용한 문헌

관련 콘텐츠

원문 URL 링크

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트